Insmed Incorporated (INSM)
NASDAQ·Healthcare·Biotechnology
$129.20
+1.54%
Mkt Cap $27.37B
Analyst Ratings
Buy
25
Hold
0
Sell
0
Price Target (65 analysts)
$204.42
Range $160.00 – $245.00
Implied Upside
+58.2%
Consensus $204.42 vs current $129.20
NASDAQ·Healthcare·Biotechnology
$129.20
+1.54%
Mkt Cap $27.37B
Buy
25
Hold
0
Sell
0
Price Target (65 analysts)
$204.42
Range $160.00 – $245.00
+58.2%
Consensus $204.42 vs current $129.20